Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 1, 2015, Pages

  Virgili, Gianni ^a   Menchini, Francesca ^b   Casazza, Giovanni ^c   Hogg, Ruth ^d   Das, Radha R ^e   Wang, Xue ^f   Michelessi, Manuele ^g  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e ROYAL VICTORIA HOSPITAL   (United Kingdom)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMICROSCOPY; CENTRAL RETINAL THICKNESS; CLINICALLY SIGNIFICANT MACULAR EDEMA; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DIAGNOSTIC ACCURACY; EYE FUNDUS; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; STANDARD; STEREOPHOTOGRAPHY; SYSTEMATIC REVIEW; COMPLICATION; DIAGNOSTIC ERROR; MACULAR EDEMA; META ANALYSIS; PATHOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA; SELECTION BIAS; SENSITIVITY AND SPECIFICITY;

DIABETIC RETINOPATHY; DIAGNOSTIC ERRORS; HUMANS; MACULAR EDEMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETINA; SELECTION BIAS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 85011092188     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008081.pub3     Document Type: Article

References (99)

1. Brown JC, Solomon SD, Bressler SB, Schachat AP, DiBernardo C, Bressler NM. Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography. Archives of Ophthalmology 2004; 122(3):330-5.
2. Browning DJ, McOwen MD, Bowen RM Jr, O'Marah TL. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology 2004;111(4):712-5.
3. Campbell RJ, Coupland SG, Buhrmann, RR, Kertes PJ. Effect of eccentric and inconsistent fixation on retinal optical coherence tomography measures. Archives of Ophthalmology 2007;125(5):619-23.
4. Davis MD, Bressler SB, Aiello LP, Bressler NM, Browning DJ, Flaxel CJ, et al. Diabetic Retinopathy Clinical Research Network Study Group. Comparison of timedomain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Investigative Ophthalmology and Visual Science 2008;49(5): 1745-52.
5. Goebel W, Franke R. Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography. Retina 2006;26(1):49-57.
6. Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG, Wilkins JR, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998; 105(2):360-70.
7. Medina FJ, Callen CI, Rebolleda G, Munoz-Negrete FJ, Callen MJ, del Valle FG. Use of nonmydriatic spectraldomain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology 2012;153(3):536-43.
8. Nunes S, Pereira I, Santos A, Bernardes R, Cunha-Vaz J. Central retinal thickness measured with HD-OCT shows a weak correlation with visual acuity in eyes with CSME. British Journal of Ophthalmology 2010;94(9):1201-4.
9. Sadda SR, Tan O,Walsh AC, Schuman JS, Varma R, Huang D. Automated detection of clinically significant macular edema by grid scanning optical coherence tomography. Ophthalmology 2006;113(7):1187-96.
10. Strom C, Sander B, Larsen N, Larsen M, Lund-Andersen H. Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography. Investigative Ophthalmology and Visual Science 2002;43(1):241-5.
11. Alkuraya H, Kangave D, Abu El-Asrar AM. The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema. International Ophthalmology 2005;26(3):93-9.
12. Bolz M, Ritter M, Schneider M, Simader C, Scholda C, Schmidt-Erfurth U. A systematic correlation of angiography and high-resolution optical coherence tomography in diabetic macular edema. Ophthalmology 2009;116(1): 66-72.
13. Deak GG, Bolz M, Ritter M, Prager S, Benesch T, Schmidt- Erfurth U. A systematic correlation between morphology and functional alterations in diabetic macular edema. Investigative Ophthalmology and Visual Science 2010;51(12): 6710-4.
14. Gaucher D, Tadayoni R, Erginay A, Haouchine B, Gaudric A, Massin P. Optical coherence tomography assessment of the vitreoretinal relationship in diabetic macular edema. Ophthalmology 2005;139(5):807-13.
15. Giovannini A, Amato GP, Mariotti C, Ripa E. Diabetic maculopathy induced by vitreo-macular traction: evaluation by optical coherence tomography (OCT). Documenta Ophthalmologica 1999;97(3-4):361-6.
16. Goebel W, Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 2002;22(6):759-67.
17. Hannouche RZ, Avila MP, Isaac DL, Silva RS, Rassi AR. Correlation between central subfield thickness, visual acuity and structural changes in diabetic macular edema. Arquivos Brasileiros de Oftalmologia 2012;75(3):183-7.
18. Lattanzio R, Brancato R, Pierro L, Bandello F, Iaccher B, Fiore T, et al. Macular thickness measured by optical coherence tomography (OCT) in diabetic patients. European Journal of Ophthalmology 2002;12(6):482-7.
19. Maheshwary AS, Oster SF, Yuson RM, Cheng L, Mojana F, Freeman WR. The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema. American Journal of Ophthalmology 2010;150(1):63-7.
20. Murakami T, Nishijima K, Akagi T, Uji A, Horii T, Ueda-Arakawa N, et al. Optical coherence tomographic reflectivity of photoreceptors beneath cystoid spaces in diabetic macular edema. Investigative Ophthalmology and Visual Science 2012;53(3):1506-11.
21. Murakami T, Nishijima K, Akagi T, Uji A, Horii T, Ueda- Arakawa N, et al. Segmentational analysis of retinal thickness after vitrectomy in diabetic macular edema. Investigative Ophthalmology and Visual Science 2012;53(10): 6668-74.
22. Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. American Journal of Ophthalmology 1999;127(6):688-93.
23. Otani T, Yamaguchi Y, Kishi S. Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. Retina 2010;30(5):774-80.
24. Özdek SC, Alper Erdinç M, Gürelik G, Aydin B, Bahçeci U, Hasanreisoglu B. Optical coherence tomographic assessment of diabetic macular edema: comparison with fluorescein angiographic and clinical findings. Ophthalmologica 2005;219(2):86-92.
25. Sanchez-Tocino H, Alvarez-Vidal A, Maldonado MJ, Moreno-Montanes J, Garcia-Layana A. Retinal thickness study with optical coherence tomography in patients with diabetes. Investigative Ophthalmology and Visual Science 2002;43(5):588-94.
26. Uji A, Murakami T, Nishijima K, Akagi T, Horii T, Arakawa N, et al. Association between hyperreflective foci in the outer retina, status of photoreceptor layer, and visual acuity in diabetic macular edema. American Journal of Ophthalmology 2012;153(4):710-7.
27. Vujosevic S, Midena E, Pilotto E, Radin PP, Chiesa L, Cavarzeran F. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings. Investigative Ophthalmology and Visual Science 2006;47(7): 3044-51.
28. Yang CS, Cheng CY, Lee FL, Hsu WM, Liu JH. Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography. Acta Ophthalmologica Scandinavica 2001;79(3):266-70.
29. American Academy of Ophthalmology Preferred Practice Patterns Committee. Retina Panel. Preferred Practice Patterns: Diabetic Retinopathy. San Francisco, CA: American Academy of Opthalmology 2012.
30. Adhi M, Duker JS. Optical coherence tomography--current and future applications. Current Opinion in Ophthalmology 2013;24(3):213-21.
31. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris III FL. Diabetic retinopathy. Diabetes Care 1998;21(1):143-56.
32. Aiello ML. Perspectives of diabetic retinopathy. American Journal of Ophthalmology 2003;136(1):122-35.
33. Alasil T, Keane PA, Updike JF, Dustin L, Ouyang Y, Walsh AC, et al. Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema. Ophthalmology 2010;117(12):2379-86.
34. Andonegui J, Zurutuza A, de Arcelus MP, Serrano L, Eguzkiza A, Auzmendi M, et al. Diabetic retinopathy screening with non-mydriatic retinography by general practitioners: 2-year results. Primary Care Diabetes 2012;6 (3):201-5.
35. Bandello F, Battaglia Parodi M, Tremolada G, Lattanzio R, De Benedetto U, Iacono P. Steroids as part of combination treatment: the future for the management of macular edema?. Ophthalmologica 2010;224(Suppl 1):41-5.
36. Bhavsar KV, Subramanian ML. Risk factors for progression of subclinical diabetic macular oedema. British Journal of Ophthalmology 2011;95(5):671-4.
37. Bossuyt PM, Leeflang MM. Chapter 6: Developing criteria for including studies. In: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 [updated September 2008]. The Cochrane Collaboration, 2008.
38. Browning DJ, Fraser CM. The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema. American Journal of Ophthalmology 2008; 145(1):149-54.
39. Browning DJ, Fraser CM, Clark S. The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology 2008;115(3):533-9.
40. Browning DJ, Altaweel MM, Bressler NM, Bressler SB, Scott IU, Diabetic Retinopathy Clinical Research Network. Diabetic macular edema: what is focal and what is diffuse?. American Journal of Ophthalmology 2008;146(5):649-55.
41. Cunningham ET Jr, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D'Amico DJ, et al. Macugen Diabetic Retinopathy Study Group. A phase II randomized doublemasked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 2005;112(10):1747-57.
42. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. Journal of Clinical Epidemiology 2005;58(9):882-93.
43. Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, Elman MJ, et al. Diabetic Retinopathy Clinical Research Network. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007;114(10):1860-7.
44. Krzystolik MG, Strauber SF, Aiello LP, Beck RW, Berger BB, Bressler NM, et al. Diabetic Retinopathy Clinical Research Network. Reproducibility of macular thickness and volume using zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology 2007; 114(8):1520-5.
45. Browning DJ, Glassman AR, Aiello LP, Beck RW, Brown DM, Fong DS, et al. Diabetic Retinopathy Clinical Research Network. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 2007;114 (3):525-36.
46. Browning DJ,GlassmanAR, Aiello LP, BresslerNM, Bressler SB, Danis RP, et al. Diabetic Retinopathy Clinical Research Network. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology 2008; 115(8):1366-71.
47. Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, et al. Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117(6): 1064-77.
48. Bressler NM, Miller KM, Beck RW, Bressler SB, Glassman AR, Kitchens JW, et al. Diabetic Retinopathy Clinical Research Network. Observational study of subclinical diabetic macular edema. Eye 2012;26(6):833-40.
49. The Diabetic Retinopathy Study Research Group. Indications for photocoagulation treatment of diabetic retinopathy. Diabetic Retinopathy Study Report Number International Ophthalmology Clinics 1987;27(4): 239-53.
50. Dukic V, Gatsonis C. Meta-analysis of diagnostic test accuracy assessment studies with varying number of thresholds. Biometrics 2003;59(4):936-46.
51. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number Archives of Ophthalmology 1985;103(12):1796-806.
52. Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Archives of Ophthalmology 1995;113(9):1144-55.
53. Forooghian F, Cukras C, Meyerle CB, Chew EY,WongWT. Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Investigative Ophthalmology and Visual Science 2008;49(10):4290-6.
54. Framme C, Schweizer P, Imesch M, Wolf S, Wolf- Schnurrbusch U. Behavior of SD-OCT-detected hyperreflective foci in the retina of anti-VEGF-treated patients with diabetic macular edema. Investigative Ophthalmology and Visual Science 2012;53(9):5814-8.
55. Glasziou P, Irwig L, Deeks JJ. When should a new test become the current reference standard?. Annals of Internal Medicine 2008;149(11):816-21.
56. Grover D, Li TJ, Chong CCW. Intravitreal steroids for macular edema in diabetes. Cochrane Database of Systematic Reviews 2008, Issue 1. DOI: 10.1002/ 14651858.CD005656.pub2
57. Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 2007;8(2):239-51.
58. Hautala N, Aikkila R, Korpelainen J, Keskitalo A, Kurikka A, Falck A, et al. Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment. Acta Ophthalmologica 2014;92(6): 582-7.
59. Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology 1989;96(2):255-64.
60. Kiernan DF, Hariprasad SM, Chin EK, Kiernan CL, Rago J, Mieler WF. Prospective comparison of cirrus and stratus optical coherence tomography for quantifying retinal thickness. American Journal of Ophthalmology 2009;147(2): 267-75.
61. Kiire CA, Porta M, Chong V. Medical management for the prevention and treatment of diabetic macular edema. Survey of Ophthalmology 2013;58(5):459-65.
62. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21(9):1414-31.
63. Kinyoun J, Barton F, Fisher M, Hubbard L, Aiello L, Ferris F. Detection of diabetic macular edema. Ophthalmoscopy versus photography--Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group. Ophthalmology 1989;96(6):746-51.
64. Leeflang MM, Moons KG, Reitsma JB, Zwinderman AH. Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. Clinical Chemistry 2008;54(4):729-37.
65. Leeang MM, Bossuyt PM, Irwig L. Diagnostic test accuracy may vary with prevalence:implications for evidence-based diagnosis. Journal of Cllinical Epidemiology 2009;62(1):5-12.
66. Liu MM,Wolfson Y, Bressler SB, Do DV, Ying HS, Bressler NM. Comparison of time- and spectral-domain optical coherence tomography in management of diabetic macular edema. Investigative Ophthalmology and Visual Science 2014; 55(3):1370-7.
67. Lord SJ, Irwig L, Simes RJ. When is measuring sensitivity and specicity sufcient to evaluate a diagnostic test, and when do we need randomized trials?. Annals of Internal Medicine 2006;144(11):850-5.
68. Lord SJ, Irwig L, Bossuyt PM. Using the principles of randomized controlled trial design to guide test evaluation. Medical Decision Making 2009;29:E1-E12.
69. Mackenzie S, Schmermer C, Charnley A, Sim D, Tah V, Dumskyj M, et al. SDOCT imaging to identify macular pathology in patients diagnosed with diabetic maculopathy by a digital photographic retinal screening programme. PloS One 2011;6(5):e14811.
70. Mansberger SL, Gleitsmann K, Gardiner S, Sheppler C, Demirel S, Wooten K, et al. Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: a randomized controlled trial. Telemedicine Journal and E-Health 2013;19 (12):942-8.
71. Mitchell P, Bressler N, Tolley K, Gallagher M, Petrillo J, Ferreira A, et al. Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial. JAMA Ophthalmology 2013;131(10):1339-47.
72. National Institute for Health and Clinical Excellence. Ranibizumab for the treatment of diabetic macular oedema Issued: NICE technology appraisal guidance 237. www.nice.org.uk/nicemedia/live/13125/55324/55324.pdf (accessed 31 October 2013).
73. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease. Diabetes in America. 2nd Edition. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, 1995.
74. Ockrim Z, Yorston D. Managing diabetic retinopathy. BMJ 2010;341:c5400.
75. Olson J, Sharp P, Goatman K, Prescott G, Scotland G, Fleming A, et al. Improving the economic value of photographic screening for optical coherence tomographydetectable macular oedema: a prospective, multicentre, UK study. Health Technology Assessment 2013;17(51):1-142.
76. Medical Advisory Secretariat. Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis. Ontario Health Technology Assessment Series 2009; Vol. 9, issue 13:1-22.
77. Peng J, Zou H, Wang W, Fu J, Shen B, Bai X, et al. Implementation and first-year screening results of an ocular telehealth system for diabetic retinopathy in China. BMC Health Services Research 2011;11:250.
78. Peto T, Tadros C. Screening for diabetic retinopathy and diabetic macular edema in the United Kingdom. Current Diabetes Reports 2012;12(4):338-45.
79. Pires I, Santos AR, Nunes S, Lobo C, Cunha-Vaz J. Subclinical macular edema as a predictor of progression to clinically significant macular edema in type 2 diabetes. Ophthalmologica 2013;230(4):201-6.
80. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005; 58(10):982-90.
81. Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 2010;33(11):2399-405.
82. Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011;118(4):615-62.
83. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
84. Schimel AM, Fisher YL, Flynn HW Jr. Optical coherence tomography in the diagnosis and management of diabetic macular edema: time-domain versus spectral-domain. Ophthalmic Surgery, Lasers and Imaging 2011;42(Suppl): S41-55.
85. Schneider EW, Mruthyunjaya P, Talwar N, Harris Nwanyanwu K, Nan B, Stein JD. Reduced fluorescein angiography and fundus photography use in the management of neovascular macular degeneration and macular edema over the past decade. Investigative Ophthalmology and Visual Science 2014;55(1):542-9.
86. Shelton RL, Jung W, Sayegh SI, McCormick DT, Kim J, Boppart SA. Optical coherence tomography for advanced screening in the primary care office. Journal of Biophotonics 2014;7(7):525-33.
87. Takwoingi Y, Deeks JJ. METADAS: A SAS macro for meta-analysis of diagnostic accuracy studies. Available at srdta.cochrane.org/software-development. The Cochrane Collaboration, 2008.
88. Vaziri K, Moshfeghi DM, Moshfeghi AA. Feasibility of telemedicine in detecting diabetic retinopathy and agerelated macular degeneration. Seminars in Ophthalmology Oct 30.
89. Virgili G, Menchini F, Dimastrogiovanni AF, Rapizzi E, Menchini U, Bandello F, et al. Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. Investigative Ophthalmology and Visual Science 2007;48(11):4963-73.
90. Virgili G, Parravano M, Menchini F, Evans JR. Antivascular endothelial growth factor for diabetic macular oedema. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD007419.pub4]
91. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology 2003;3:25.
92. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155(8):529-36.
93. World Health Organization. The World Health Report www.who.int/whr/en.
94. Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 2004;18(10): 963-83.
95. Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, Iliev ME, Frey M, Rothenbuehler SP, et al. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Investigative Ophthalmology and Visual Science 2009;50(7):3432-7.
96. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35(3):556-64.
97. Yohannan J, Bittencourt M, Sepah YJ, Hatef E, Sophie R, Moradi A, et al. Association of retinal sensitivity to integrity of photoreceptor inner/outer segment junction in patients with diabetic macular edema. Ophthalmology 2013;120(6): 1254-61.
98. Virgili G, Menchini F, Murro V, Peluso E, Rosa F, Casazza G. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD008081]
99. Virgili G, Menchini F, Murro V, Peluso E, Rosa F, Casazza G. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD008081.pub2]